PRESS RELEASE
Villers-lès-Nancy, 22 November 2013 - 18:00 (CET)
The PHARMAGEST Group consolidates its know-how in the financing of pharmacies.
Representing France's leading player for pharmacy computerisation, the PHARMAGEST Group has extended its position in the pharmacy financing sector with the announcement of the finalisation of its complete equity stake in the HEALTHLEASE company, which thus becomes a wholly owned subsidiary of the PHARMAGEST Group.
HEALTHLEASE specialises in the financing of medical equipment and benefits from unique know-how in this field. In 2012, HEALTHLEASE recorded a net income of €0.92 million.
Since 2010, the PHARMAGEST Group has entrusted HEALTHLEASE with all operations for the financing of its customers.
This transaction allows the PHARMAGEST Group to be fully self-sufficient in terms of the financing of its customers and their security.
This latest commitment to pharmacists for the financing of their dispensaries is in keeping with the PHARMAGEST Group's strategy to provide pharmacists with efficient support, thereby allowing them to fully focus on their new missions for accompanying and advising patients.
Through this immediately accretive acquisition, the PHARMAGEST Group now seeks to appeal to a wider audience of healthcare actors (retirement homes or other care facilities) by proposing suitable financing solutions.
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 700 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.
As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for laboratories.
The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centres for the elderly), through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, dynamises sales, optimises purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.
At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecuRTM).
Listed on the NYSE Euronext Paris(TM) - Compartment B
Eligible for the Long-Only Deferred Settlement Service (SRD)
Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
Find out the latest news from the group at www.pharmagest.com
CONTACTS
Chairman of the Board:
Thierry CHAPUSOT
Chief Executive Officer:
Dominique PAUTRAT
Tel. 03 83 15 90 67 - dominique.pautrat@pharmagest.com
Analyst and Investor Relations:
Administrative and Financial Director: Jean-Yves SAMSON
Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com
Press relations:
FIN'EXTENSO - Isabelle APRILE
Tel.01 39 97 61 22 - i.aprile@finextenso.fr
